Background: Internal dosimetry evaluation consists of a multi-step process ranging from imaging acquisition to absorbed dose calculations. Assessment of uncertainty is complicated and, for that reason, it is commonly ignored in clinical routine. However, it is essential for adequate interpretation of the results. Recently, the EANM published a practical guidance on uncertainty analysis for molecular radiotherapy based on the application of the law of propagation of uncertainty. In this study, we investigated the overall uncertainty on a sample of patient following the EANM guidelines. The aim of this study was to provide an indication of the typical uncertainties that may be expected from performing dosimetry, to determine parameters that have the greatest effect on the accuracy of calculations and to consider the potential improvements that could be made if these effects were reduced.
Results: Absorbed doses and the relative uncertainties were calculated for a sample of 49 patients and a total of 154 tumours. A wide range of relative absorbed dose uncertainty values was observed (14 - 102%). Uncertainties associated with each quantity along the absorbed dose calculation chain (i.e. Volume, Recovery Coefficient, Calibration Factor, Activity, Time-Activity Curve Fitting, Time-Integrated Activity and Absorbed Dose) were estimated. An equation was derived to describe relationship between the uncertainty in the absorbed dose and the volume. The largest source of error was the VOI delineation. By postulating different values of FWHM, the impact of the imaging system spatial resolution on the uncertainties was investigated.
Discussion: To the best of our knowledge, this is the first analysis of uncertainty in molecular radiotherapy based on a cohort of clinical cases. Wide inter-lesion variability of absorbed dose uncertainty was observed. Hence, a proper assessment of the uncertainties associated with the calculations should be considered as a basic scientific standard. A model for a quick estimate of uncertainty without implementing the entire error propagation schema, which may be useful in clinical practice, was presented. Ameliorating spatial resolution may be in future the key factor for accurate absorbed dose assessment.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8
The full text of this article is available to read as a PDF.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Posted 11 Sep, 2020
Received 16 Sep, 2020
On 16 Sep, 2020
Received 15 Sep, 2020
Invitations sent on 08 Sep, 2020
On 08 Sep, 2020
On 08 Sep, 2020
On 07 Sep, 2020
On 06 Sep, 2020
On 06 Sep, 2020
On 11 Aug, 2020
Received 02 Aug, 2020
Received 02 Aug, 2020
On 18 Jul, 2020
On 18 Jul, 2020
Invitations sent on 14 Jul, 2020
On 13 Jul, 2020
On 12 Jul, 2020
On 12 Jul, 2020
On 15 Jun, 2020
Received 09 Jun, 2020
Received 02 Jun, 2020
On 25 May, 2020
On 25 May, 2020
Invitations sent on 12 May, 2020
On 11 May, 2020
On 10 May, 2020
On 08 May, 2020
On 06 May, 2020
Posted 11 Sep, 2020
Received 16 Sep, 2020
On 16 Sep, 2020
Received 15 Sep, 2020
Invitations sent on 08 Sep, 2020
On 08 Sep, 2020
On 08 Sep, 2020
On 07 Sep, 2020
On 06 Sep, 2020
On 06 Sep, 2020
On 11 Aug, 2020
Received 02 Aug, 2020
Received 02 Aug, 2020
On 18 Jul, 2020
On 18 Jul, 2020
Invitations sent on 14 Jul, 2020
On 13 Jul, 2020
On 12 Jul, 2020
On 12 Jul, 2020
On 15 Jun, 2020
Received 09 Jun, 2020
Received 02 Jun, 2020
On 25 May, 2020
On 25 May, 2020
Invitations sent on 12 May, 2020
On 11 May, 2020
On 10 May, 2020
On 08 May, 2020
On 06 May, 2020
Background: Internal dosimetry evaluation consists of a multi-step process ranging from imaging acquisition to absorbed dose calculations. Assessment of uncertainty is complicated and, for that reason, it is commonly ignored in clinical routine. However, it is essential for adequate interpretation of the results. Recently, the EANM published a practical guidance on uncertainty analysis for molecular radiotherapy based on the application of the law of propagation of uncertainty. In this study, we investigated the overall uncertainty on a sample of patient following the EANM guidelines. The aim of this study was to provide an indication of the typical uncertainties that may be expected from performing dosimetry, to determine parameters that have the greatest effect on the accuracy of calculations and to consider the potential improvements that could be made if these effects were reduced.
Results: Absorbed doses and the relative uncertainties were calculated for a sample of 49 patients and a total of 154 tumours. A wide range of relative absorbed dose uncertainty values was observed (14 - 102%). Uncertainties associated with each quantity along the absorbed dose calculation chain (i.e. Volume, Recovery Coefficient, Calibration Factor, Activity, Time-Activity Curve Fitting, Time-Integrated Activity and Absorbed Dose) were estimated. An equation was derived to describe relationship between the uncertainty in the absorbed dose and the volume. The largest source of error was the VOI delineation. By postulating different values of FWHM, the impact of the imaging system spatial resolution on the uncertainties was investigated.
Discussion: To the best of our knowledge, this is the first analysis of uncertainty in molecular radiotherapy based on a cohort of clinical cases. Wide inter-lesion variability of absorbed dose uncertainty was observed. Hence, a proper assessment of the uncertainties associated with the calculations should be considered as a basic scientific standard. A model for a quick estimate of uncertainty without implementing the entire error propagation schema, which may be useful in clinical practice, was presented. Ameliorating spatial resolution may be in future the key factor for accurate absorbed dose assessment.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8
The full text of this article is available to read as a PDF.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...